Cases & Deals

Blue Point Capital sells controlling interest in TREK Diagnostic Systems

Clients Blue Point Capital Partners

Jones Day advised Blue Point Capital Partners in connection with the sale of a controlling interest in TREK Diagnostic Systems, a global provider of products for microbiology labs, to Magellan Biosciences, Inc.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.